• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.78% Nasdaq Down 1.13%

    Novavax, Inc. (NVAX)

    -NasdaqGS
    5.03 Down 0.29(5.45%) May 3, 4:00PM EDT
    Prev Close:5.32
    Open:5.21
    Bid:5.08 x 1000
    Ask:5.65 x 200
    1y Target Est:14.32
    Beta:1.81733
    Next Earnings Date: 4-May-16NVAX Earnings announcement
    Day's Range:5.01 - 5.27
    52wk Range:4.08 - 15.01
    Volume:4,757,769
    Avg Vol (3m):6,590,360
    Market Cap:1.36B
    P/E (ttm):N/A
    EPS (ttm):-0.60
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    NVAXDown 5.45%1.36B
    MRKDown 0.40%152.56B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):39.62
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-16) :-0.88
    Quarterly EPS Est (Mar-16) :-0.27
    Mean Recommendation*:1.6
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Novavax, Inc., a clinical-stage vaccine company, focuses on discovering, developing, and commercializing recombinant nanoparticle vaccines and adjuvants. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback